Citations

B.R.I.D.G.E. TO DATA® has been utilized in several published studies and cited in relevant textbooks and presentations.
Below is a list of some of these citations:
  • Hartzema AG, Tilson HH, Chan KA, eds. Pharmacoepidemiology and Therapeutic Risk Management. Cincinatti, OH: Harvey Whitney Books, 2008. ISBN-10: 0929375300; ISBN-13: 978-0929375304.

  • Dominique M, Azmi S, Reginald P, Verpillat P, Francois C. A review of accessibility of administrative healthcare databases in the Asia-Pacific region. Journal of Market Access & Health Policy. 2015;3:28076.

  • Rascati, Karen L. Essentials of Pharmacoeconomics. Second ed. Baltimore, Maryland: Lippincott Williams & Wilkins, 2014. ISBN: 978-1-4511-7593-6.

  • Scales CD Jr, Lai JC, Dick AW, Hanley JM, van Meijgaard J, Setodji CM, Saigal CS. Urologic Diseases in America Project. Comparative effectiveness of shock wave lithotripsy and ureteroscopy for treating patients with kidney stones. JAMA Surg. 2014 Jul;149(7):648-53.

  • Schumock GT, Lee TA, Pickard AS, Lee W, Patel H, Dilokthornsakul P, Shoaibi A, Archdeacon P. Alternative Methods For Health Outcomes Of Interest Validation. Mini-Sentinel Methods. 2013 Aug 31;1-141.

  • Mini - Sentinel Methods; Alternative Methods For Health Outcomes of Interest Validation. Prepared by: Glen T. Schumock, Todd A. Lee, A. Simon Pickard, Wan-Ju Lee, Hari Patel, Piyameth Dilokthornsakul, Azadeh Shoaibi, Patrick Archdeacon. August 13, 2013. http://www.mini-sentinel.org/work_products/Validation_HealthOutcomes/Mini-Sentinel-Alternative-Methods-for-Health-Outcomes-of-Interest-Validation.pdf

  • McKoy JM, Fisher MJ, Courtney DM, Raisch DW, Edwards BJ, Scheetz MH, Belknap SM, Trifilio SM, Samaras AT, Liebling DB, Nardone B, Tulas KM, West DP. Results from the first decade of research conducted by the Research on Adverse Drug Events and Reports (RADAR) project. Drug Saf. 2013 May;36(5):335-47

  • Oshima Y, Ikematsu H, Yuji K, Tanimoto T, Tojo A. Exposure to acetaminophen and potential risk of abnormal behaviors reported in influenza and non-influenza patients. Case-control study with the Japan Adverse Drug Event Reporting. WebmedCentral HEALTH INFORMATICS. 2013;4(12):WMC004452.

  • Ferrajolo C, Li Y, Verhamme K, Fregonese F, Bonifazi D, Osokogu O, de Bie S, Wong I, Weibel D, Bonhoeffer J, Sturkenboom M (GRIP). Description of Data Sources: A report on the identified healthcare databases and their characteristics plus literature on their experience with respect to paediatric studies. Revision date July 1, 2012. http://www.grip-network.org/uploads/assets/WP2/GRIP-D2.2-Description_of_Data_Sources.pdf